Mitchell Shirvan, CSO of Silexion Therapeutics SLXN, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $31K. The latest trade was on 06/04.

MS

MS

Mitchell Shirvan

CSO and CDO

Company

Silexion Therapeutics SLXN

First filing

26/03/30

Trades

3 trades

Buys / sales

0 / 1

12-month net buying

−$31K

Last trade

06/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Silexion TherapeuticsSLXN	Open-market sale	03/26	03/30	22,818 sh	$1.36	$31,032.48	−45.0%